Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2017 December;58(6) > The Journal of Cardiovascular Surgery 2017 December;58(6):889-94

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEW  RECENT DEVELOPMENTS IN JUXTARENAL AND AORTO-ILIAC INTERVENTIONS


The Journal of Cardiovascular Surgery 2017 December;58(6):889-94

DOI: 10.23736/S0021-9509.17.10072-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Type II endoleaks: when and how

Matthew J. GRIMA , Alan KARTHIKESALINGAM

St George’s Vascular Institute, St George’s University of London, London, UK


PDF  


Although most type II endoleaks are self-limiting, the most common indication for secondary intervention after endovascular aneurysm repair (EVAR) is type II endoleak. However, it is still debatable when to treat them. Furthermore, different intervention techniques are available to treat type II endoleaks. The aim of this review is to look at current evidence and updates on type II endoleaks after EVAR for abdominal aortic aneurysm and their management.


KEY WORDS: Endoleak - Aortic aneurysm - Epidemiology

top of page

Publication History

Issue published online: September 14, 2017
Article first published online: June 19, 2017
Manuscript accepted: June 17, 2017
Manuscript received: June 15, 2017

Cite this article as

Grima MJ, Karthikesalingam A. Type II endoleaks: when and how. J Cardiovasc Surg 2017;58:889-94. DOI: 10.23736/S0021-9509.17.10072-8

Corresponding author e-mail

matthewjoe.grima@gmail.com